RE: Chart6 Nov 2024 10:38
Nigel Theobald yesterday on LinkedIn: 'Great first day at BioEurope, plenty of interest in our IBD program, 15 meetings today and 16 more tomorrow'.
Also received via email this morning the very first N4 Pharma newsletter, looks like N4 are expecting to be much more active over the coming months.